US 11306104
Solid state forms of Relugolix
granted A61KA61K9/0053A61P
Quick answer
US patent 11306104 (Solid state forms of Relugolix) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K9/0053, A61P, A61P15/00, A61P35/00